Linking Direct to Consumer Genomics and Electronic Health Records to Accelerate Science
直接连接消费者基因组学和电子健康记录以加速科学发展
基本信息
- 批准号:10195133
- 负责人:
- 金额:$ 23.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-15 至 2023-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdultAdvertisingAlcohol consumptionAlcoholsAppointmentCaringChronic Obstructive Airway DiseaseClinical and Translational Science AwardsComplementComplexConsumptionDataData SetDatabasesDevelopmentDiseaseElectronic Health RecordFutureGeneticGenetic DiseasesGenetic ResearchGenetic studyGenomicsGenotypeGoalsHealthHealth trendsHealthcareHealthcare SystemsHeart DiseasesIndividualInformed ConsentInfrastructureInstitutionInterviewLinkLung diseasesMalignant NeoplasmsMalignant neoplasm of lungMedicalMissouriModelingNational Institute of Drug AbuseNicotineOutcomeParticipantPatient CarePatient RecruitmentsPatientsPerformancePersonsPhenotypePopulationPrizeProtocols documentationProviderPublic HealthQuestionnairesResearchResearch PersonnelResearch Project GrantsResourcesRiskSample SizeSamplingScheduleScienceSmokingSystemTestingThinkingTimeTranslationsUnited States National Institutes of HealthUpdateWorkaddictionbasecitizen sciencecohortcommunity engagementcostcost effectivedata repositorydata resourcedata warehousedesigneligible participantexperiencefollow-upgenome wide association studygenome-widegenomic datainnovationinterestmobile computingnovelnovel strategiespolygenic risk scoreprogramsprototyperecruitrepositoryrisk predictionsmartphone Applicationsocial mediasubstance usetooltrait
项目摘要
Abstract
Very large sample sizes are needed in genetic studies of complex traits and medical illnesses, and collecting
such samples is expensive and time intensive. To accelerate complex genetic discovery and translation, it is
critical to harness existing data quickly and efficiently. The goal of our proposal is to implement a novel and
scalable online/mobile recruitment paradigm to harness the vast amount of genomic data generated through
direct-to-consumer testing and to link these data to a research data warehouse containing electronic health
record (EHR) information from the BJC Healthcare System. We will accomplish our goal in three aims: 1)
Finalize online/mobile tools for recruiting consumer genomics customers who also are patients from the BJC
Healthcare system. We have designed an online/mobile approach that enables participants to provide us with
informed consent, their individual-level 23andMe genome-wide genotypes, and the key information required to
link their genomic data to their research based EHR data. 2) Recruit a cohort of 23andMe customers who are
also patients from the BJC Healthcare system to build a database linking their genotypes and EHR. We aim to
recruit 10,000 participants by year 2, based on the size of the 23andMe sampling base, the size of the BJC
Healthcare population, and the eligible participants we have already identified. 3) Building on our previous
work, we will evaluate the performance of polygenic risk scores (PRS) for substance use phenotypes to predict
health outcomes such as heart disease, COPD, lung cancer, and related traits. These analyses will be a proof
of principle to test of the value of this database. Our electronic recruitment strategy can be easily adapted to
recruitment for a variety of studies, and we will share our recruitment tools and details of our repository
infrastructure with research institutions through the network developed as part of NIH Clinical and Translational
Sciences Awards.
It is critical that moving forward we make more efficient use of research resources, focusing on establishing
data resources that can be used repeatedly in the future as opposed to recruiting participants to answer a
single research question. By integrating online recruitment, existing genomic data, and research based
electronic health records in a novel approach, our recruitment paradigm can rapidly attain the large cohorts
needed for complex disease genetics research in a cost-effective manner. This approach will enable
researchers to effectively target emerging health trends and research needs quickly and efficiently, and this
approach complements the large-scale efforts underway such as All of Us.
抽象的
在复杂性状和医学疾病的遗传研究中需要非常大的样本量,并收集
这样的样品很昂贵且耗时。为了加速复杂的遗传发现和翻译,它是
对利用现有数据至关重要。我们建议的目的是实施小说,
可扩展的在线/移动招聘范式来利用通过
直接到消费者测试,并将这些数据与包含电子健康的研究数据仓库联系起来
来自BJC医疗保健系统的记录(EHR)信息。我们将在三个目标中实现我们的目标:1)
最终确定在线/移动工具,用于招募消费者基因组学客户,他们也是BJC的患者
医疗保健系统。我们设计了一种在线/移动方法,使参与者能够为我们提供
知情同意,他们的个人级别23和全基因组基因型以及所需的关键信息
将其基因组数据与基于研究的EHR数据联系起来。 2)招募一个由23AndMe客户组成
也是BJC医疗保健系统的患者,以构建连接其基因型和EHR的数据库。我们的目标
根据23andMe采样基础的规模,招募了10,000名参与者,BJC的大小
医疗保健人口以及我们已经确定的合格参与者。 3)在我们以前的
工作,我们将评估用于使用表型的多基因风险评分(PR)的性能
健康结果,例如心脏病,COPD,肺癌和相关特征。这些分析将是证明
原理测试该数据库的价值。我们的电子招聘策略可以轻松适应
招聘各种研究,我们将分享我们的招聘工具和存储库的详细信息
通过网络与研究机构的基础设施作为NIH临床和转化的一部分开发
科学奖。
至关重要的是,向前迈进,我们更有效地利用了研究资源,重点是建立
将来可以反复使用的数据资源,而不是招募参与者回答
单个研究问题。通过整合在线招聘,现有基因组数据和基于研究的基础
电子健康记录在一种新颖的方法中,我们的招聘范式可以迅速达到大型队列
复杂疾病遗传学研究所需的以具有成本效益的方式进行。这种方法将启用
研究人员有效地针对新兴的健康趋势和研究需求,以快速有效的效率
方法补充了我们所有人等大规模努力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Laura J. Bierut其他文献
Genetik der Nikotinabhängigkeit
尼古丁的遗传学
- DOI:
- 发表时间:
2010 - 期刊:
- 影响因子:0
- 作者:
Sarah M. Hartz;Laura J. Bierut - 通讯作者:
Laura J. Bierut
Laura J. Bierut的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Laura J. Bierut', 18)}}的其他基金
Multi 'Omics Integration and Neurobiological Signatures of Alcohol Use Disorder
酒精使用障碍的多组学整合和神经生物学特征
- 批准号:
10461091 - 财政年份:2019
- 资助金额:
$ 23.63万 - 项目类别:
Multi 'Omics Integration and Neurobiological Signatures of Alcohol Use Disorder
酒精使用障碍的多组学整合和神经生物学特征
- 批准号:
10023922 - 财政年份:2019
- 资助金额:
$ 23.63万 - 项目类别:
Multi 'Omics Integration and Neurobiological Signatures of Alcohol Use Disorder
酒精使用障碍的多组学整合和神经生物学特征
- 批准号:
10678775 - 财政年份:2019
- 资助金额:
$ 23.63万 - 项目类别:
Washington University Career Development Program in Drug Abuse and Addiction
华盛顿大学药物滥用和成瘾职业发展计划
- 批准号:
9917745 - 财政年份:2017
- 资助金额:
$ 23.63万 - 项目类别:
Washington University Career Development Program in Drug Abuse and Addiction
华盛顿大学药物滥用和成瘾职业发展计划
- 批准号:
10657611 - 财政年份:2017
- 资助金额:
$ 23.63万 - 项目类别:
Washington University Career Development Program in Drug Abuse and Addiction
华盛顿大学药物滥用和成瘾职业发展计划
- 批准号:
10460704 - 财政年份:2017
- 资助金额:
$ 23.63万 - 项目类别:
Nicotine Dependence to Smoking Cessation: Sequencing Common and Rare Variants
戒烟对尼古丁的依赖:对常见和罕见变异进行测序
- 批准号:
8839761 - 财政年份:2014
- 资助金额:
$ 23.63万 - 项目类别:
Nicotine Dependence to Smoking Cessation: Sequencing Common and Rare Variants
戒烟对尼古丁的依赖:对常见和罕见变异进行测序
- 批准号:
9271304 - 财政年份:2014
- 资助金额:
$ 23.63万 - 项目类别:
Nicotine Dependence to Smoking Cessation: Sequencing Common and Rare Variants
戒烟对尼古丁的依赖:对常见和罕见变异进行测序
- 批准号:
8722284 - 财政年份:2014
- 资助金额:
$ 23.63万 - 项目类别:
相似国自然基金
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
- 批准号:82302025
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
- 批准号:82302311
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Appalachian Tobacco Regulatory Science Team (AppalTRuST)
阿巴拉契亚烟草监管科学团队 (AppalTRuST)
- 批准号:
10665319 - 财政年份:2023
- 资助金额:
$ 23.63万 - 项目类别:
The Unvarnished Truth: Pursuing Health Equity by Correcting Disinformation Targeting African Americans about the FDA's Proposed Ban on Menthol Cigarettes and Flavored Cigars
赤裸裸的真相:通过纠正针对非裔美国人的关于 FDA 提议禁止薄荷卷烟和调味雪茄的虚假信息来追求健康公平
- 批准号:
10740281 - 财政年份:2023
- 资助金额:
$ 23.63万 - 项目类别:
Effects of State Preemption of Local Tobacco Control Legislation on Disparities in Tobacco Use, Exposure and Retail
国家抢先实施地方烟草控制立法对烟草使用、接触和零售差异的影响
- 批准号:
10681733 - 财政年份:2023
- 资助金额:
$ 23.63万 - 项目类别:
Effects of Nicotine Concentration Levels in E-cigarettes on Biomarkers of Exposure to Toxicants and Tobacco Use Behaviors
电子烟中尼古丁浓度水平对有毒物质暴露和烟草使用行为生物标志物的影响
- 批准号:
10678555 - 财政年份:2023
- 资助金额:
$ 23.63万 - 项目类别: